1. Home
  2. MATH vs VTGN Comparison

MATH vs VTGN Comparison

Compare MATH & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MATH
  • VTGN
  • Stock Information
  • Founded
  • MATH 2015
  • VTGN 1998
  • Country
  • MATH Hong Kong
  • VTGN United States
  • Employees
  • MATH N/A
  • VTGN N/A
  • Industry
  • MATH Finance/Investors Services
  • VTGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • MATH Finance
  • VTGN Health Care
  • Exchange
  • MATH Nasdaq
  • VTGN Nasdaq
  • Market Cap
  • MATH 60.8M
  • VTGN 59.8M
  • IPO Year
  • MATH N/A
  • VTGN N/A
  • Fundamental
  • Price
  • MATH $3.60
  • VTGN $2.38
  • Analyst Decision
  • MATH
  • VTGN
  • Analyst Count
  • MATH 0
  • VTGN 0
  • Target Price
  • MATH N/A
  • VTGN N/A
  • AVG Volume (30 Days)
  • MATH 197.9K
  • VTGN 306.2K
  • Earning Date
  • MATH 08-26-2025
  • VTGN 08-12-2025
  • Dividend Yield
  • MATH N/A
  • VTGN N/A
  • EPS Growth
  • MATH N/A
  • VTGN N/A
  • EPS
  • MATH 0.17
  • VTGN N/A
  • Revenue
  • MATH $31,399,049.00
  • VTGN $486,000.00
  • Revenue This Year
  • MATH N/A
  • VTGN N/A
  • Revenue Next Year
  • MATH N/A
  • VTGN $943.32
  • P/E Ratio
  • MATH $22.72
  • VTGN N/A
  • Revenue Growth
  • MATH 291.58
  • VTGN N/A
  • 52 Week Low
  • MATH $0.80
  • VTGN $1.90
  • 52 Week High
  • MATH $4.17
  • VTGN $4.21
  • Technical
  • Relative Strength Index (RSI)
  • MATH 61.32
  • VTGN 55.71
  • Support Level
  • MATH $3.55
  • VTGN $1.99
  • Resistance Level
  • MATH $3.97
  • VTGN $2.63
  • Average True Range (ATR)
  • MATH 0.32
  • VTGN 0.15
  • MACD
  • MATH 0.03
  • VTGN 0.05
  • Stochastic Oscillator
  • MATH 83.49
  • VTGN 60.87

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Share on Social Networks: